Indeed, α1AT is the most abundant inhibitor of NSPs in plasma and α1AT deficiency (AATD) is the most important genetic predisposition to emphysema and chronic obstructive pulmonary disease, where proteases drive the pathology. This evidence concerns the gene SERPINA1 and pulmonary emphysema.